167 related articles for article (PubMed ID: 37900425)
61. Clinical Diagnostic Implications of Body Fluid MiRNA in Oral Squamous Cell Carcinoma: A Meta-Analysis.
Tian X; Chen Z; Shi S; Wang X; Wang W; Li N; Wang J
Medicine (Baltimore); 2015 Sep; 94(37):e1324. PubMed ID: 26376377
[TBL] [Abstract][Full Text] [Related]
62. MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma.
Ganci F; Sacconi A; Manciocco V; Sperduti I; Battaglia P; Covello R; Muti P; Strano S; Spriano G; Fontemaggi G; Blandino G
Head Neck; 2016 Apr; 38 Suppl 1():E189-97. PubMed ID: 25532855
[TBL] [Abstract][Full Text] [Related]
63. Reciprocal change in Glucose metabolism of Cancer and Immune Cells mediated by different Glucose Transporters predicts Immunotherapy response.
Na KJ; Choi H; Oh HR; Kim YH; Lee SB; Jung YJ; Koh J; Park S; Lee HJ; Jeon YK; Chung DH; Paeng JC; Park IK; Kang CH; Cheon GJ; Kang KW; Lee DS; Kim YT
Theranostics; 2020; 10(21):9579-9590. PubMed ID: 32863946
[TBL] [Abstract][Full Text] [Related]
64. Characterisation of glucose transporter (GLUT) gene expression in broiler chickens.
Kono T; Nishida M; Nishiki Y; Seki Y; Sato K; Akiba Y
Br Poult Sci; 2005 Aug; 46(4):510-5. PubMed ID: 16268111
[TBL] [Abstract][Full Text] [Related]
65. Immunohistochemical Evaluation of Glucose Transporter Type 1 in Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Pereira KM; Feitosa SG; Lima AT; Luna EC; Cavalcante RB; de Lima KC; Chaves FN; Costa FW
Asian Pac J Cancer Prev; 2016; 17(1):147-51. PubMed ID: 26838200
[TBL] [Abstract][Full Text] [Related]
66. Bioinformatics based exploration of hsa-miR-194-5p regulation of CHD4 through PI3K/AKT signal pathway to enhance tumor resistance to apoptosis due to loss of nests and participate in poor prognosis of oral squamous cell carcinoma.
Li Q; Wang K; Shen Y; Lin C; Miao J; Hu X
Ann Transl Med; 2023 Jan; 11(2):107. PubMed ID: 36819582
[TBL] [Abstract][Full Text] [Related]
67. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.
Tian M; Zhang H; Nakasone Y; Mogi K; Endo K
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):5-12. PubMed ID: 14551748
[TBL] [Abstract][Full Text] [Related]
68. Functional Landscape of Dysregulated MicroRNAs in Oral Squamous Cell Carcinoma: Clinical Implications.
Ghosh RD; Pattatheyil A; Roychoudhury S
Front Oncol; 2020; 10():619. PubMed ID: 32547936
[TBL] [Abstract][Full Text] [Related]
69. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors?
Elmahgoub F
Evid Based Dent; 2022 Mar; 23(1):30-31. PubMed ID: 35338326
[TBL] [Abstract][Full Text] [Related]
70. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
71. Evaluating the expression of microRNA-15a-5p and YAP1 gene in oral squamous cell carcinoma in comparison with normal tissue: A cross-sectional study.
Saravana Murthy P; Kannan A; Ganesan A; Lakshmi KC; Aniyan Kumbalaparambil Y
J Oral Pathol Med; 2023 Aug; 52(7):593-600. PubMed ID: 37285474
[TBL] [Abstract][Full Text] [Related]
72. MiRNA-101 inhibits oral squamous-cell carcinoma growth and metastasis by targeting zinc finger E-box binding homeobox 1.
Wu B; Lei D; Wang L; Yang X; Jia S; Yang Z; Shan C; Yang X; Zhang C; Lu B
Am J Cancer Res; 2016; 6(6):1396-407. PubMed ID: 27429852
[TBL] [Abstract][Full Text] [Related]
73. Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney.
Heilig C; Zaloga C; Lee M; Zhao X; Riser B; Brosius F; Cortes P
Lab Invest; 1995 Nov; 73(5):674-84. PubMed ID: 7474941
[TBL] [Abstract][Full Text] [Related]
74. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
[TBL] [Abstract][Full Text] [Related]
75. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
[TBL] [Abstract][Full Text] [Related]
76. Distinct Prognostic Values of the mRNA Expression of Glucose Transporters in Non-Small Cell Lung Cancer.
Du H; Liu Y; Yuan Y; Zhang Y; Geng H
Ann Clin Lab Sci; 2020 Jul; 50(4):481-489. PubMed ID: 32826245
[TBL] [Abstract][Full Text] [Related]
77. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
[TBL] [Abstract][Full Text] [Related]
78. MiRNA s in oesophageal squamous cancer.
Chu Y; Zhu H; Lv L; Zhou Y; Huo J
Neth J Med; 2013 Mar; 71(2):69-75. PubMed ID: 23462054
[TBL] [Abstract][Full Text] [Related]
79. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
[TBL] [Abstract][Full Text] [Related]
80. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
